February 6-7, 2020

4th Edition MarketsandMarkets Genome Editing & Engineering Conference

San Diego , CA
20+
Speakers
150+
Attendees
10
Networking Hours
5+
Sessions

Since our past editions we dedicated our focus on the latest developments and addressed various applications of CRISPR as a molecular tool, gene expression, knock-in, genomic screening, along with therapeutic developments through animal modeling. Attended by 100+ genome editing professionals and 20+ gene expert speakers, the event saw participation of big companies like Casebia Therapeutics, Genentech, BMS, Cellectis , University of Laval, University of California, Center of Advanced Genome Engineering, Georgia Tech, Stanford University, Locana, Harvard Medical School, Agility, Poseida, Vertex, Ligandal, Integrated DNA Technologies, GE Healthcare, Cellecta, Agilent, Advanced Analytical, Thermofisher, Atum, Synthego, New England Biolabs, Aldevron, Applied Stem Cell and more.

users

Leading experts and professionals from pharmaceuticals and academia will outline breakthrough advancements in pre-clinical & clinical therapeutics using genome Editing. The event will also focus on analysis of off target effects, specificity and aspects of gene and cellular therapies

users

The conference will attract CEO, CSO, VP, Directors, Scientists, Researchers, Heads, Managers, Professors, PHD students and many more from the Genome Editing & Engineering field.

users

The two day event will invite 150+ genome editing professional, 20+ experts speakers and 15+ solution/technology providers at an unique platform to deliver niche buyer-seller ecosystem in the genomic world.

In 2020, coming with the 4th Edition Genome Editing & Engineering Conference on 6th & 7th February in San Diego, we are getting ahead by discussing the commercialization and advancements of technology which will outline breakthrough advancements in pre-clinical & clinical therapeutics using genome Editing. The event will also focus on analysis of off target effects, specificity and aspects of gene and cellular therapies.

WHAT TO EXPECT
Key Highlights

• Allogenic Car-T cells
• Off target effects
• Stem cell immunotherapy
• Specificity of CRISPR
• Multiplexity of genes
• Viral and non-viral gene delivery
• Ethical issues
• T-cell proliferation
• DNA repair & DNA toxicity removal
• Next-gen cell and gene therapy
• Electroporation and cell engineering

Who should attend?

Professors, Lecturers Research scientist/fellows from Universities and Research Institutes from departments of:
Genome editing | Genome engineering | Functional genomics | Gene therapy | Cell therapy | Disease modeling | Gene regulation | Heads, Chief scientific officers, Research scientists, Laboratory managers from pharmaceuticals, bio-pharma and therapeutics companies from departments of: 
Genome biology | Drug discovery and R&D | Genetics | Computational biology | Gene & Cell therapy

CONFERENCE AGENDA
CONFERENCE SPEAKERS
Advisors
Robert Nitsch

Robert Nitsch

Associate Director-CRISPR Safety
AstraZeneca

Robert Nitsch

Associate Director-CRISPR Safety
AstraZeneca
C.B. Gurumurthy

C.B. Gurumurthy

Director Transgenic Core Facility
University of Nebraska Medical Center

C.B. Gurumurthy

Director Transgenic Core Facility
University of Nebraska Medical Center
Jacques Tremblay

Jacques Tremblay

Full Professor, Department of Molecular Medicine
University of Laval

Jacques Tremblay

Full Professor, Department of Molecular Medicine
University of Laval
Speakers
Shailendra Singh (Shelly)

Shailendra Singh (Shelly)

Chief Operating Officer
MarketsandMarkets

Shailendra Singh (Shelly)

Chief Operating Officer
MarketsandMarkets
Robert Nitsch

Robert Nitsch

Associate Director-CRISPR Safety
AstraZeneca

Robert Nitsch

Associate Director-CRISPR Safety
AstraZeneca
C.B. Gurumurthy

C.B. Gurumurthy

Director Transgenic Core Facility
University of Nebraska Medical Center

C.B. Gurumurthy

Director Transgenic Core Facility
University of Nebraska Medical Center
Jacques Tremblay

Jacques Tremblay

Full Professor, Department of Molecular Medicine
University of Laval

Jacques Tremblay

Full Professor, Department of Molecular Medicine
University of Laval
Ana Moreno

Ana Moreno

CEO
Naviga Therapeutics

Ana Moreno

CEO
Naviga Therapeutics
Matthew R. Willmann

Matthew R. Willmann

Director Plan Transformation Facility
Cornell University

Matthew R. Willmann

Director Plan Transformation Facility
Cornell University
Mazhar Adli

Mazhar Adli

Associate Professor of Molecular Biology and Genetic
University of Virginia

Mazhar Adli

Associate Professor of Molecular Biology and Genetic
University of Virginia
Eugene Barsov

Eugene Barsov

Senior Research Scientist
Gilead Sciences/Kite Pharma

Eugene Barsov

Senior Research Scientist
Gilead Sciences/Kite Pharma
LOCATION
San Diego , CA

Please contact us on events@marketsandmarkets.com to get the hotel booking link.

About the Hotel

For any queries regarding the hotel booking please write to us at events@marketsandmarkets.com

Hotel Booking Link

You will receive a link to book your accommodation via email once you are fully registered. (Please note that we do not authorize any 3rd party agencies (e.g. Exhibitors Housing Management) to book on our behalf and, occasionally, companies fraudulently try to represent us. If you are contacted by anyone other than us regarding your accommodation requirements for this event, please let us know immediately on events@marketsandmarkets.com

PAST EVENT GALLERY